Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter
- PMID: 37062767
- PMCID: PMC10106464
- DOI: 10.1038/s41598-023-33164-5
Initiating and imaging cavitation from infused echo contrast agents through the EkoSonic catheter
Abstract
Ultrasound-enhanced delivery of therapeutic-loaded echogenic liposomes is under development for vascular applications using the EkoSonic Endovascular System. In this study, fibrin-targeted echogenic liposomes loaded with an anti-inflammatory agent were characterized before and after infusion through an EkoSonic catheter. Cavitation activity was nucleated by Definity or fibrin-targeted, drug-loaded echogenic liposomes infused and insonified with EkoSonic catheters. Passive cavitation imaging was used to quantify and map bubble activity in a flow phantom mimicking porcine arterial flow. Cavitation was sustained during 3-min infusions of Definity or echogenic liposomes along the distal 6 cm treatment zone of the catheter. Though the EkoSonic catheter was not designed specifically for cavitation nucleation, infusion of drug-loaded echogenic liposomes can be employed to trigger and sustain bubble activity for enhanced intravascular drug delivery.
© 2023. The Author(s).
Conflict of interest statement
Boston Scientific provided the EkoSonic Endovascular System control unit and catheters. C.G. is a retired employee and shareholder of Boston Scientific Inc, and CKH and KJH are consultants with Boston Scientific Inc. S.H., M.E.K. and D.D.M. are shareholders and board members of Zymo Pharmaceuticals, LLC. All other co-authors have no conflicts of interest to disclose.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
